A CMR-derived model, including mass morphology and tissue characterization, showed excellent accuracy, superior to echocardiography, in predicting CMs malignancy, with prognostic implications Pasquale Paolisso Luca Bergamaschi @belmontemarta Alberto Foà ahajrnls.org/3IMbKBX

In this video, Alberto Foà discusses a PARAGON-HF analysis from #ACC24 examining treatment-related hypotension in people with HFmrEF/HFpEF. hcplive.com/view/alberto-f… #HeartFailure

The CMR Mass Score: 🎯A CMR-derived model, including mass morphology and tissue characterization, showed excellent accuracy, superior to echo, in predicting CMs’ malignancy, with prognostic implications. Read more about our results on 👇Circulation ahajournals.org/doi/10.1161/CI…

Proud that our paper on #CMR to predict Cardiac Masses Malignancy is in the 🚀top 6 most read articles of 2024 so far in #CirculationCardiovascularImaging ahajournals.org/doi/10.1161/CI… #TheCMRMassScore🧲🫀

🔥In HTx recipients, FAI was an independent predictor of MACEs and allograft rejection. 🎯FAI assessment could be part of CCTA analysis in routine surveillance of HTx recipients! Read more of our group's simultaneous publication during #ESCCongress2024 in JACC Journals #JACCIMG

In HTx recipients, FAI was an independent predictor of MACEs and allograft rejection. FAI assessment could be part of CCTA analysis in routine surveillance of HTx recipients, potentially improving pts' care. bit.ly/4g81p2X #JACCIMG #ESCCongress Angelo Sansonetti

First data of SGLT2i in AS pts - PART 2 🔥In T2DM pts w/ severe AS, LVEF<50%, and cardiac damage undergoing TAVI, the SGLT2i use was associated w/ a more favorable cardiac remodeling and ⬇️risk of MACE A 2-loop-year FU. Read more on 👇#CardiovascularDiabetology cardiab.biomedcentral.com/articles/10.11…

📢 Our meta-analysis on pathological findings at invasive assessment in MINOCA is out on Heart_BMJ 🔍 53% have non-obs CAD, with an ⬆️risk of all-cause death or MI at 1-yr and long-term FU compared w/ pts w/ normal coronary artery, mainly due to a ⬆️risk of MI. 🔬 OCT &

Cardiac masses often represent a challenge for clinicians, particularly in terms of Dx. Multimodality #cvImaging now offers a unique opportunity to cost-effectively improve the Dx, mgmt, & potentially outcomes of pts w/ cardiac masses. jacc.org/doi/10.1016/j.… #JACCCardioOnc #CMR

Non-invasive vs. Invasive Approach to Cardiac Allograft Vasculopathy Surveillance: The Role of Coronary CT Angiography (CCTA-HTx Study) 👉 is now out on CircImaging ! Our main findings were: 🔥The combination of CCTA-derived coronary DS (DS>35%) and plaque morphology (plaque

Our State-of-the-Art Review on Multimodality Imaging in the Diagnostic Work-Up of Patients With Cardiac Masses is now out on @JACCCardioOncology JACC Journals 👇 sciencedirect.com/science/articl… Role of current multimodality imaging and future directions for their applications: 👥For

Thrilled to see our study featured in the Journal Scan 🔎of the American College of Cardiology! 🎉 Grateful to our team for the hard work 💪 and to American College of Cardiology for this recognition. 🏅 Carmine Pizzi Luca Bergamaschi Pasquale Paolisso Marta Belmonte Lisa Canton Alberto Foà Università di Bologna

📢 Periprocedural myocardial injury and infarction are common in NSTEMI patients undergoing PCI and are associated with worse outcomes. 🔎 Learn more in Circulation American Heart Association American Heart News 👉 ahajournals.org/doi/10.1161/CI…

💊SGLT2i pleiotropic effects have demonstrated efficacy across various cardiovascular conditions, ranging from acute to chronic coronary syndromes and extending to arrhythmias, valvular heart disease, cardiomyopathies, cardio-oncology, and cerebrovascular disease! 🔍Our review

🩺 Non perdere il Journal Club del Gruppo di Studio SIC Fisiopatologia coronarica e microcircolazione! 📅 Giovedì 8 maggio 🕜 13:30 – 14:00 🔗 Link per iscriversi: us06web.zoom.us/webinar/regist… SIC Società Italiana di Cardiologia

🎯To evaluate the impact of #SGLT2i on the risk of acute kidney injury (AKI) in #T2DM pts w/ severe #AS undergoing #TAVI. 👥 Multicenter Registry of consecutive pts stratified by the presence of CKD and anti-diabetic therapy (2021-2024). 🔥Our main findings were: - SGLT2i

🎯 To assess the association of glucometabolic parameters w/ T4aMI in NSTEMI pts undergoing PCI. 🩸Admission blood glucose (ABG), glycated hemoglobin (HbA1c), and stress hyperglycemia ratio (SHR) were tested. 👥 Consecutive NSTEMI patients undergoing PCI from the AMIPE